Status:
COMPLETED
COMPLliancE and qualiTy of lifE in Asthma
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Asthma
Compliance, Patient
Eligibility:
All Genders
18-80 years
Brief Summary
A multicenter, open, non-interventional, prospective, clinical observational study on Conformity to Therapy and Quality of Life in Asthma in patients living in Greece
Detailed Description
Dry powder devices, available since 1970, have been developed to make inhalation simpler than pMDIs and relieve the need for co-ordination of spraying and inhalation, which is particularly important f...
Eligibility Criteria
Inclusion
- Male or female asthma patients over 18 years of age
- Compliance with treatment
- Compliance with study procedures
- Signed informed consent form
- Patients not satisfactorily controlled with inhaled corticosteroids and the use of inhaled short-acting β2-primers or patients already adequately controlled with both inhaled corticosteroids and long-acting β2-stimulants:
- Patients receiving ICS inhaled and SABA invoked
- Patients receiving inhaled ICS and LABA with separate devices each
- Patients receiving periodic and not continuously stable combination of ICS and LABA but not being treated for at least 1 month
- Patients who did not receive any treatment and the doctor decides to immediately start the fixed combination of ICS and LABA
Exclusion
- Male or female asthma patients under 18 years of age
- Unsigned patient consent
- Non-compliance with treatment
- Non-compliance in study procedures
- COPD patients (at any stage)
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03300076
Start Date
February 1 2018
End Date
December 1 2018
Last Update
December 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sotiria Pulmonary Hospital
Athens, Greece